 SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a clinical-stage biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at these upcoming investor conferences: 